Search results
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks· 5 days agoFree Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing ...
Bill Maher Batters His Buddy RFK Jr. Over Anti-Vax Claims
The Daily Beast via Yahoo News· 1 day agoHBOBill Maher took presidential candidate Robert F. Kennedy Jr. to task on Friday’s episode of Real...
What Factors Will Drive Pfizer's Q1 Performance?
Forbes· 3 days agoWe expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
Pfizer collab with Austrian research institute leads to new AI models for drug discovery
FierceBiotech· 2 days agoA three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 5 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
Pfizer Vs Moderna Battle Over COVID Vaccine Patents Begins in UK
US News & World Report· 5 days agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal ...
FDA Approves Second Gene Therapy for Hemophilia B
Medscape· 3 days agoPfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 5 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
What is divestment? And does it work?
CNN Business via Yahoo Finance· 7 hours agoChicago PMI for April and the Conference Board releases consumer confidence for April. Wednesday: Earnings from Mastercard, Qualcomm, Pfizer, Marriott,...
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B
Market Watch· 2 days agoPfizer has won Food and Drug Administration approval of Beqvez, a one-time gene therapy for certain patients with the inherited bleeding disorder hemophilia B. The New York ...
